The thin spines were found to have no difference among the groups of intact control, stroke vehicle control and stroke SCF+G-CSF treatment at 6 weeks post-treatment (Figure 3F and G, P>0.05) (one- way ANOVA: T-type, F(2,6) = 1.05, P = 0.41). The gene discussed is CSF3; the disease is stroke disorder.